CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has reached an …